Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Phospholamban antibody (N-Term)

This anti-Phospholamban antibody is a Rabbit Polyclonal antibody detecting Phospholamban in WB. Suitable for Human. This Primary Antibody has been cited in 4+ publications.
Catalog No. ABIN1882182

Quick Overview for Phospholamban antibody (N-Term) (ABIN1882182)

Target

See all Phospholamban (PLN) Antibodies
Phospholamban (PLN)

Reactivity

  • 86
  • 24
  • 22
  • 3
  • 2
  • 2
  • 2
Human

Host

  • 87
  • 3
  • 1
Rabbit

Clonality

  • 86
  • 5
Polyclonal

Conjugate

  • 44
  • 6
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This Phospholamban antibody is un-conjugated

Application

  • 37
  • 35
  • 26
  • 26
  • 22
  • 11
  • 10
  • 9
  • 9
  • 9
  • 7
  • 6
  • 1
  • 1
Western Blotting (WB)

Clone

RB44799
  • Binding Specificity

    • 26
    • 17
    • 12
    • 9
    • 8
    • 7
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-22, N-Term

    Predicted Reactivity

    B, M, Pig, Rb, Rat

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This PLN antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-22 amino acids from the N-terminal region of human PLN.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Kaliman, Catalucci, Lam, Kondo, Gutiérrez, Reddy, Palacín, Zorzano, Chien, Ruiz-Lozano: "Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum." in: The Journal of biological chemistry, Vol. 280, Issue 9, pp. 8016-21, (2005) (PubMed).

    Minamisawa, Sato, Tatsuguchi, Fujino, Imamura, Uetsuka, Nakazawa, Matsuoka: "Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy." in: Biochemical and biophysical research communications, Vol. 304, Issue 1, pp. 1-4, (2003) (PubMed).

    McTiernan, Frye, Lemster, Kinder, Ogletree-Hughes, Moravec, Feldman: "The human phospholamban gene: structure and expression." in: Journal of molecular and cellular cardiology, Vol. 31, Issue 3, pp. 679-92, (1999) (PubMed).

    Fujii, Zarain-Herzberg, Willard, Tada, MacLennan: "Structure of the rabbit phospholamban gene, cloning of the human cDNA, and assignment of the gene to human chromosome 6." in: The Journal of biological chemistry, Vol. 266, Issue 18, pp. 11669-75, (1991) (PubMed).

  • Target

    Phospholamban (PLN)

    Alternative Name

    PLN

    Background

    Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2 Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. ATP2A2 inhibition is alleviated by PLN phosphorylation.

    Molecular Weight

    6109

    UniProt

    P26678

    Pathways

    Negative Regulation of Transporter Activity
You are here:
Chat with us!